Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,631649,Bp123,Blood pressure QTL 123,3.2,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),3,94788365,139788365,Rat,n/a,region,qtl 1000,1331758,Bp207,Blood pressure QTL 207,2.848,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),3,117303473,141971336,Rat,n/a,region,qtl 1000,1598877,Bp285,Blood pressure QTL 285,1.5,0.03,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),3,128986468,173986468,Rat,n/a,region,qtl 1000,631541,Bp81,Blood pressure QTL 81,4,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),3,129787213,177699992,Rat,n/a,region,qtl 1000,7387306,Bw124,Body weight QTL 124,3.2,0.0003,body mass (VT:0001259),body weight (CMO:0000012),3,88910015,133910015,Rat,n/a,region,qtl 1000,8694437,Bw167,Body weight QTL 167,22.46,0.001,retroperitoneal fat pad mass (VT:0010430),retroperitoneal fat pad weight to body weight ratio (CMO:0000635),3,97009185,142009185,Rat,n/a,region,qtl 1000,2301970,Bw81,Body weight QTL 81,5.19,,body mass (VT:0001259),body weight (CMO:0000012),3,43295930,163640485,Rat,n/a,region,qtl 1000,2312670,Bw94,Body weight QTL 94,,0.01,inguinal fat pad mass (VT:0010424),inguinal fat pad weight to body weight ratio (CMO:0001253),3,103141814,176418101,Rat,n/a,region,qtl 1000,70216,Cm14,Cardiac mass QTL 14,2.1,,heart mass (VT:0007028),heart wet weight (CMO:0000069),3,30846101,172879276,Rat,n/a,region,qtl 1000,724532,Cm17,Cardiac mass QTL 17,2,,heart mass (VT:0007028),calculated heart weight (CMO:0000073),3,101058963,146058963,Rat,n/a,region,qtl 1000,2301971,Cm71,Cardiac mass QTL 71,4.63,,heart left ventricle mass (VT:0007031),heart left ventricle weight (CMO:0000776),3,43295930,163640485,Rat,n/a,region,qtl 1000,1354611,Despr2,Despair related QTL 2,3.03,0.0028,locomotor behavior trait (VT:0001392),amount of time spent in voluntary immobility (CMO:0001043),3,102466149,147466149,Rat,n/a,region,qtl 1000,1559282,Emca5,Estrogen-induced mammary cancer QTL 5,3.9,,mammary gland integrity trait (VT:0010552),percentage of study population developing mammary tumors during a period of time (CMO:0000948),3,45406058,177699992,Rat,n/a,region,qtl 1000,2292591,Esta4,Estrogen-induced thymic atrophy QTL 4,,,thymus mass (VT:0004954),thymus wet weight (CMO:0000855),3,48561928,155263151,Rat,n/a,region,qtl 1000,2302373,Gluco39,Glucose level QTL 39,5.01,,blood glucose amount (VT:0000188),blood glucose level area under curve (AUC) (CMO:0000350),3,103141944,170934860,Rat,n/a,region,qtl 1000,2293087,Iddm27,Insulin dependent diabetes mellitus QTL 27,2.68,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),3,102152812,155263151,Rat,n/a,region,qtl 1000,1358204,Insglur1,Insulin/glucose ratio QTL 1,3.8,,blood glucose amount (VT:0000188),serum glucose level (CMO:0000543),3,120917788,141971336,Rat,n/a,region,qtl 1000,1358204,Insglur1,Insulin/glucose ratio QTL 1,3.8,,blood glucose amount (VT:0000188),serum insulin level (CMO:0000358),3,120917788,141971336,Rat,n/a,region,qtl 1000,1300159,Kidm4,Kidney mass QTL 4,3.83,,kidney mass (VT:0002707),right kidney wet weight to body weight ratio (CMO:0001953),3,126575595,165355668,Rat,n/a,region,qtl 1000,631841,Niddm39,Non-insulin dependent diabetes mellitus QTL 39,3.36,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),3,99465522,168732722,Rat,n/a,region,qtl 1000,1581546,Pur13,Proteinuria QTL 13,2.93,0.0335,total urine protein amount (VT:0000032),urine protein excretion rate (CMO:0000759),3,81136227,154416635,Rat,n/a,region,qtl 1000,1300173,Rf11,Renal function QTL 11,3.38,,renal blood flow trait (VT:2000006),absolute change in renal blood flow rate (CMO:0001168),3,126575595,153412619,Rat,n/a,region,qtl 1000,619618,Rf3,Renal disease susceptibility QTL 3,6.5,0.001,urine albumin amount (VT:0002871),urine albumin excretion rate to body weight ratio (CMO:0001270),3,114376250,159376250,Rat,n/a,region,qtl 1000,1581568,Rf53,Renal function QTL 53,,,total urine protein amount (VT:0000032),urine protein excretion rate to body weight ratio (CMO:0001099),3,58204463,170534769,Rat,n/a,region,qtl 1000,1576306,Schws3,Schwannoma susceptibility QTL 3,,0.001,nervous system integrity trait (VT:0010566),percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017),3,125848628,170848628,Rat,n/a,region,qtl 1000,2312673,Scl63,Serum cholesterol level QTL 63,,0.001,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),3,103141814,176418101,Rat,n/a,region,qtl 1000,2312659,Slep7,Serum leptin concentration QTL 7,,0.001,blood leptin amount (VT:0005667),serum leptin level (CMO:0000780),3,103141814,176418101,Rat,n/a,region,qtl 1000,1358362,Srcrt2,Stress Responsive Cort QTL 2,2.78,,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),3,39248391,140271184,Rat,n/a,region,qtl 1000,1578754,Stresp16,Stress response QTL 16,4,0.001,blood renin amount (VT:0003349),plasma renin activity level (CMO:0000116),3,119471263,164471263,Rat,n/a,region,qtl 1000,8662816,Vetf4,Vascular elastic tissue fragility QTL 4,4,,renal artery integrity trait (VT:0010642),number of ruptures of the internal elastic lamina of the renal arteries (CMO:0002563),3,61241033,165369047,Rat,n/a,region,qtl